New evaluation reports on tapentadol, and oxycodone/naloxone (Targinact)

3rd Mar 2015

Two new evaluation reports on tapentadol, and oxycodone/naloxone (Targinact) for the treatment of chronic pain are now online. These reviews aim to give objective information and guidance including efficacy, adverse effects, place in treatment and arrangements for prescribing to commissioners of health services, prescribers and others.

These documents are available from our Evaluation Reports page.